Reply to Drs. Olanow and Rascol
- PMID: 20368636
- PMCID: PMC2865778
- DOI: 10.1212/WNL.0b013e3181d7d93b
Reply to Drs. Olanow and Rascol
Comment on
-
The delayed-start study in Parkinson disease: can't satisfy everyone.Neurology. 2010 Apr 6;74(14):1149-50. doi: 10.1212/WNL.0b013e3181d7d94b. Neurology. 2010. PMID: 20368635 No abstract available.
References
-
- Parkinson Study Group. Effect of deprenyl on the progression of disability in early Parkinson's disease. N Engl J Med 1989;321:1364–1371. - PubMed
-
- Parkinson Study Group. Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. N Engl J Med 1993;328:176–183. - PubMed
-
- Elm J, Goetz C, Ravina B, et al. A responsive outcome for Parkinson's disease neuroprotection futility studies. Ann Neurol 2005;57:197–203. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical